SE8405493D0
(sv)
*
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
US5314642A
(en)
*
|
1984-11-27 |
1994-05-24 |
Igen, Inc. |
Interaction system comprising a surfactant-stabilized aqueous phase containing an antibody fragment
|
EP0231039B1
(en)
*
|
1986-01-14 |
1992-01-08 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Process for preparing immunological complexes and pharmaceutical composition containing these complexes
|
US4806350A
(en)
*
|
1986-04-18 |
1989-02-21 |
Norden Laboratories, Inc. |
Vaccine formulation
|
CA1331355C
(en)
*
|
1986-04-21 |
1994-08-09 |
Bioenterprises Pty. Ltd |
Immunopotentation
|
FR2598434B1
(fr)
*
|
1986-05-12 |
1988-09-16 |
Pf Medicament |
Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
|
US4888169A
(en)
*
|
1986-10-14 |
1989-12-19 |
Norden Laboratories, Inc. |
Bordetella Bronchiseptica vaccine
|
EP0270295A3
(en)
*
|
1986-12-03 |
1989-08-02 |
Connaught Laboratories Limited |
Conjugate vaccine
|
US5976839A
(en)
*
|
1987-03-13 |
1999-11-02 |
Bioenterprises Pty Limited |
Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules
|
FR2614306B1
(fr)
*
|
1987-04-22 |
1989-07-28 |
Pf Medicament |
Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.
|
US5043158A
(en)
*
|
1987-08-21 |
1991-08-27 |
Chembiomed, Ltd. |
Immunogenic compositions containing ordered carriers
|
DE3727987A1
(de)
*
|
1987-08-21 |
1989-03-02 |
Sleytr Uwe B |
Pharmazeutische struktur
|
US5178860A
(en)
*
|
1989-09-01 |
1993-01-12 |
Coopers Animal Health Limited |
Adjuvant complexes and vaccine made therefrom
|
JPH049015U
(da)
*
|
1990-05-09 |
1992-01-27 |
|
|
NL9002314A
(nl)
*
|
1990-10-23 |
1992-05-18 |
Nederlanden Staat |
Immunogene complexen, in het bijzonder iscoms.
|
US6676942B1
(en)
|
1991-08-15 |
2004-01-13 |
Smithkline Beecham Biologicals (S.A.) |
Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
|
AU666326B2
(en)
*
|
1991-08-15 |
1996-02-08 |
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts |
Osp A proteins of borrelia burgdorferi subgroups, encoding genes and vaccines
|
GB9207731D0
(en)
*
|
1992-04-07 |
1992-05-27 |
Proteus Molecular Design |
Improvements in or relating to vaccines
|
EP0604727A1
(en)
*
|
1992-12-31 |
1994-07-06 |
American Cyanamid Company |
Improved immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen
|
JP4129544B2
(ja)
*
|
1993-03-29 |
2008-08-06 |
ファイザー・インク |
サポニンアジュバント使用の多成分系クロストリジウム・ワクチン
|
JPH0756123A
(ja)
*
|
1993-08-20 |
1995-03-03 |
Nakanishi Opt:Kk |
眼鏡フレーム
|
GB9320597D0
(en)
*
|
1993-10-06 |
1993-11-24 |
Proteus Molecular Design |
Improvements in and realting to vaccines
|
AUPM500494A0
(en)
*
|
1994-04-12 |
1994-05-05 |
Minister For Agriculture & Rural Affairs For The State Of New South Wales, The |
Composition for use in increasing mucosal immunity
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
DK0805855T3
(da)
*
|
1995-01-27 |
2007-06-25 |
Genencor Int |
Overfladeaktivt middel-baseret enzymekstraktionsproces
|
US20030190323A1
(en)
*
|
1995-07-05 |
2003-10-09 |
Yeda Research And Development Co. Ltd. |
Preparations and methods for the treatment of T cell mediated diseases
|
US6488933B2
(en)
|
1995-07-05 |
2002-12-03 |
Yeda Research And Development Co. Ltd. |
Preparations for the treatment of T cell mediated diseases
|
IL114458A0
(en)
*
|
1995-07-05 |
1995-11-27 |
Yeda Res & Dev |
Therapeutic preparations for treatment of T cell mediated diseases
|
AUPO517897A0
(en)
|
1997-02-19 |
1997-04-11 |
Csl Limited |
Chelating immunostimulating complexes
|
AUPO732997A0
(en)
|
1997-06-12 |
1997-07-03 |
Csl Limited |
Ganglioside immunostimulating complexes and uses thereof
|
US6455323B1
(en)
|
1997-07-03 |
2002-09-24 |
Pharmacia & Upjohn Company |
Anti-bacterial methods and materials
|
EP0967484B1
(en)
|
1997-08-04 |
2007-05-02 |
Advanced Life Science Institute, Inc. |
Methods for detecting or assaying virus
|
ID29082A
(id)
*
|
1998-09-22 |
2001-07-26 |
Molecular Express Inc |
Komposisi liposom imunogenik
|
GB2348203B
(en)
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
ES2572834T3
(es)
|
1999-02-17 |
2016-06-02 |
Csl Limited |
Complejos inmunogénicos y métodos relacionados con los mismos
|
ES2535961T3
(es)
|
1999-04-09 |
2015-05-19 |
Zoetis P&U Llc |
Bacteria pasteurelácea atenuada que tiene una mutación en un gen de virulencia
|
US6790950B2
(en)
|
1999-04-09 |
2004-09-14 |
Pharmacia & Upjohn Company |
Anti-bacterial vaccine compositions
|
BR0109322A
(pt)
|
2000-03-17 |
2002-12-10 |
Upjohn Co |
Materiais e métodos de vacina de salmonella
|
US6764823B2
(en)
|
2000-04-06 |
2004-07-20 |
Pharmacia & Upjohn Company |
Antimicrobial methods and materials
|
US7323174B1
(en)
|
2000-06-12 |
2008-01-29 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Modulation of immune response and methods based thereon
|
AUPR011700A0
(en)
|
2000-09-14 |
2000-10-05 |
Austin Research Institute, The |
Composition comprising immunogenic virus sized particles (VSP)
|
US7094351B2
(en)
|
2000-10-12 |
2006-08-22 |
Corcoran Robert C |
Purification of substances by reaction affinity chromatography
|
US7713942B2
(en)
*
|
2001-04-04 |
2010-05-11 |
Nordic Vaccine Technology A/S |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
|
GB0112126D0
(en)
|
2001-05-18 |
2001-07-11 |
Allergene Inc |
Composition
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
WO2003074068A2
(en)
*
|
2002-03-01 |
2003-09-12 |
Trillium Therapeutics Inc. |
Use of soluble fgl2 as an immunosuppressant
|
SE0202110D0
(sv)
*
|
2002-07-05 |
2002-07-05 |
Isconova Ab |
Iscom preparation and use thereof
|
JP2005535350A
(ja)
|
2002-08-12 |
2005-11-24 |
アクゾ・ノベル・エヌ・ベー |
ストレプトコッカス・ユベリス蛋白質、前記蛋白質をコードする核酸配列及び乳腺炎ワクチンにおけるその使用
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
US7301554B2
(en)
*
|
2002-09-20 |
2007-11-27 |
Ricoh Company, Ltd. |
Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method
|
US20050026859A1
(en)
*
|
2002-11-12 |
2005-02-03 |
John Hilfinger |
Methods and compositions of gene delivery agents for systemic and local therapy
|
EP1578443B1
(en)
|
2002-11-20 |
2011-01-12 |
Bestewil Holding B.V. |
Compositions comprising antigen-complexes, method for making same as well as methods of using the antigen-complexes for vaccination
|
US7491395B2
(en)
|
2002-11-20 |
2009-02-17 |
Bestewil Holding B.V. |
Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
|
AR056245A1
(es)
|
2003-06-19 |
2007-10-03 |
Bestewil Holding Bv |
Membranas virales reconstituidas funcionales que contienen un coadyuvante
|
GB0315323D0
(en)
|
2003-07-01 |
2003-08-06 |
Royal Veterinary College |
Vaccine composition
|
US9023366B2
(en)
|
2003-07-01 |
2015-05-05 |
The Royal Veterinary College |
Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
|
EP1755666B1
(en)
|
2004-05-28 |
2010-12-15 |
GlaxoSmithKline Biologicals SA |
Vaccine compositions comprising virosomes and a saponin adjuvant
|
AU2006257383A1
(en)
|
2005-06-16 |
2006-12-21 |
Universiteit Gent |
Vaccines for immunization against Helicobacter
|
BRPI0614119B8
(pt)
|
2005-07-28 |
2017-04-11 |
Pah Usa 15 Llc |
vacina para imunizar gatos contra calicivírus de felino
|
RS20080138A
(en)
|
2005-10-07 |
2009-07-15 |
Pfizer Products Inc., |
Vaccines and methods to treat canine influenza
|
TW200806315A
(en)
*
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
PT2762163T
(pt)
|
2006-12-27 |
2018-02-22 |
Zoetis Services Llc |
Métodos de administração de vacina
|
EP3381445B1
(en)
*
|
2007-11-15 |
2023-10-25 |
Amgen Inc. |
Aqueous formulation of antibody stablised by antioxidants for parenteral administration
|
BRPI0821558A2
(pt)
*
|
2007-12-21 |
2015-11-03 |
Wyeth Llc |
virus da estomatite vesicular atenuado geneticamente modificado, ecomposições e métodos de uso dessas
|
RU2010151562A
(ru)
|
2008-06-20 |
2012-07-27 |
ВАЙЕТ ЭлЭлСи (US) |
Композиции и способы применения orf1358 из бета-гемолитических стрептококковых штаммов
|
ES2729934T3
(es)
|
2009-06-22 |
2019-11-07 |
Wyeth Llc |
Composiciones y procedimientos para preparar composiciones inmunogénicas de conjugado de polisacárido capsular de serotipo 8 de Staphylococcus aureus
|
AR078601A1
(es)
|
2009-06-22 |
2011-11-23 |
Wyeth Llc |
Composiciones inmunogenicas de antigenos de staphylococcus aureus
|
BR112012009309B1
(pt)
|
2009-10-19 |
2021-10-05 |
Intervet International B.V |
Vacina combinada, uso de células de microrganismos,método para a preparação de uma vacina combinada, e, kit de partes
|
CA2777159A1
(en)
|
2009-10-22 |
2011-04-28 |
Universitat Leipzig |
Detection of a circovirus in calves suffering from bovine neonatal pancytopenia
|
EP2560985B1
(en)
|
2010-04-21 |
2016-06-29 |
Pharmaq AS |
Nucleic acid sequences of a fish virus and the use thereof
|
SI2569008T1
(sl)
|
2010-05-14 |
2020-02-28 |
Baxalta Incorporated |
Himere OSPA in njihova uporaba v cepivih
|
DK2575870T3
(da)
|
2010-06-04 |
2017-02-13 |
Wyeth Llc |
Vaccineformuleringer
|
WO2012010291A1
(en)
|
2010-07-21 |
2012-01-26 |
Athera Biotechnologies Ab |
Diagnostic and therapeutic methods and compositions for metabolic disease
|
WO2012010290A1
(en)
|
2010-07-21 |
2012-01-26 |
Athera Biotechnologies Ab |
Diagnostic and therapeutic methods and compositions for metabolic disease
|
EP3272359A1
(en)
|
2010-07-23 |
2018-01-24 |
Novavax AB |
Influenza vaccine
|
CA2808975C
(en)
|
2010-08-23 |
2018-10-30 |
Wyeth Llc |
Stable formulations of neisseria meningitidis rlp2086 antigens
|
US8628947B2
(en)
|
2010-08-30 |
2014-01-14 |
Intervet Inc. |
Potomac horse fever isolates
|
JP5976652B2
(ja)
|
2010-09-10 |
2016-08-24 |
ワイス・エルエルシー |
髄膜炎菌orf2086抗原の非脂質化変異体
|
EP2635593B1
(en)
|
2010-11-05 |
2016-09-14 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Vaccines for preventing meningococcal infections
|
NO2640832T3
(da)
|
2010-11-15 |
2018-05-19 |
|
|
EP2462950A1
(en)
|
2010-12-08 |
2012-06-13 |
Neovacs |
Strongly inactivated and still highly immunogenic vaccine, and process of manufacturing thereof
|
BR112013014302A2
(pt)
|
2010-12-08 |
2016-09-20 |
Neovacs |
vacina fortemente inativada e ainda altamente imunogênica e processo de fabricação da mesma
|
MX350170B
(es)
|
2010-12-22 |
2017-08-28 |
Wyeth Llc |
Composición inmunogénica estable de antígenos de staphylococcus aureus.
|
US20130287786A1
(en)
|
2010-12-29 |
2013-10-31 |
Theodorus Petrus Maria Schetters |
Canine babesiosis vaccine antigen
|
WO2012089749A1
(en)
|
2010-12-29 |
2012-07-05 |
Intervet International B.V. |
Salmonid alphavirus protein e2
|
EP2691111B1
(en)
|
2011-03-31 |
2017-09-20 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
|
BR112013025892B1
(pt)
|
2011-04-07 |
2021-01-19 |
Neovacs |
produto imunogênico, forma de dosagem unitária, dispositivo médico e kit relacionados a ifna
|
EP2508197A1
(en)
|
2011-04-07 |
2012-10-10 |
Neovacs |
Method for treating IFNalpha related conditions
|
EP3251692B1
(en)
|
2011-05-13 |
2023-09-27 |
Zoetis Services LLC |
Hendra and nipah virus g glycoprotein immunogenic compositions
|
ITMI20111182A1
(it)
|
2011-06-28 |
2012-12-29 |
Canio Buonavoglia |
Vaccino per coronavirus canino
|
EP2734619B1
(en)
*
|
2011-07-20 |
2017-09-06 |
BGP Products B.V. |
Process for producing orthomyxoviral antigen and vaccines
|
AR087811A1
(es)
|
2011-09-08 |
2014-04-16 |
Umc Utrecht Holding Bv |
Vacuna contra el staphylococcus aureus
|
WO2013051994A1
(en)
|
2011-10-03 |
2013-04-11 |
Moreinx Ab |
Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
|
GB201200259D0
(en)
|
2012-01-09 |
2012-02-22 |
Ohlin Per M |
Novel therapies
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
CN104334187B
(zh)
|
2012-03-09 |
2017-04-05 |
辉瑞公司 |
脑膜炎双球菌组合物及其方法
|
JP2015524802A
(ja)
|
2012-07-27 |
2015-08-27 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
キメラospa分子を含む組成物およびその使用方法
|
CA2943263C
(en)
|
2012-12-20 |
2018-12-04 |
Pfizer Inc. |
Glycoconjugation process
|
JP6446377B2
(ja)
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
US10294277B2
(en)
|
2013-03-26 |
2019-05-21 |
The Pirbright Institute |
Stabilised FMDV capsids
|
US9907846B2
(en)
|
2013-04-01 |
2018-03-06 |
Mx Adjuvac Ab |
Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
|
WO2015033251A2
(en)
|
2013-09-08 |
2015-03-12 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
US20160331829A1
(en)
|
2013-12-16 |
2016-11-17 |
Zoetis Services Llc |
Hendra and nipah virus g glycoprotein immunogenic compositions
|
WO2016130569A1
(en)
|
2015-02-09 |
2016-08-18 |
Mj Biologics, Inc. |
A composition comprising pedv antigens and methods for making and using the composition
|
ES2702325T3
(es)
|
2014-03-11 |
2019-02-28 |
Univ Minnesota |
Vacunas contra el virus de la diarrea epidémica porcina y métodos de uso de las mismas
|
CA2957472C
(en)
|
2014-09-03 |
2021-10-26 |
Intervet International B.V. |
Attenuated bovine coronavirus and related vaccines
|
EP3200820B1
(en)
|
2014-10-03 |
2023-07-05 |
Intervet International B.V. |
Broad-spectrum vaccine against avian reovirus
|
EP3207055A1
(en)
|
2014-10-15 |
2017-08-23 |
Xenothera |
Composition with reduced immunogenicity
|
CN107249626A
(zh)
|
2015-02-19 |
2017-10-13 |
辉瑞大药厂 |
脑膜炎奈瑟球菌组合物及其方法
|
ES2834880T3
(es)
|
2015-03-10 |
2021-06-21 |
Bio Rad Laboratories |
Prueba combinada de sífilis treponémica y no treponémica
|
MX368897B
(es)
|
2015-05-04 |
2019-10-21 |
Pfizer |
Conjugados proteina-polisacarido de estreptococo grupo b, metodos para producir conjugados, composiciones inmunogenas que comprenden conjugados y sus usos.
|
JP6670374B2
(ja)
|
2015-09-03 |
2020-03-18 |
ノババックス,インコーポレイテッド |
改善された安定性および免疫原性を有するワクチン組成物
|
GB2551984B
(en)
|
2016-06-30 |
2019-01-16 |
Pharmaq As |
Fish virus
|
CA3033759C
(en)
|
2016-08-17 |
2022-06-14 |
Pharmaq As |
Sea lice vaccine
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
KR102567845B1
(ko)
|
2017-01-31 |
2023-08-17 |
화이자 인코포레이티드 |
네이세리아 메닌기티디스 조성물 및 그의 방법
|
CA3075853A1
(en)
|
2017-09-18 |
2019-03-21 |
Bayer Healthcare Llc |
Methods of inactivation of viruses using n-methylglucamide and its derivatives
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
EP4136095A1
(en)
|
2020-04-17 |
2023-02-22 |
Regents of the University of Minnesota |
Sars-cov-2 spike receptor binding domain and compositions and methods thereof
|
EP3922255A1
(en)
|
2020-06-10 |
2021-12-15 |
Prokarium Limited |
Cancer therapy
|
CA3192786A1
(en)
|
2020-08-26 |
2022-03-03 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
JP2024500935A
(ja)
|
2020-12-23 |
2024-01-10 |
ゼノセラ |
抗感染受動免疫療法における、抗体依存性マクロファージ炎症誘発性サイトカインの放出を治療及び/又は予防するためのその使用のためのブタポリクローナル抗体組成物
|
EP4124342A1
(en)
|
2021-07-28 |
2023-02-01 |
Prokarium Limited |
Cancer therapy with live attenuated bacteria
|
GB2622559A
(en)
|
2022-05-10 |
2024-03-27 |
Johan Frostegaard |
Compositions, methods and uses
|
WO2023225458A1
(en)
|
2022-05-16 |
2023-11-23 |
Zoetis Services Llc |
Vaccines against moritella viscosa
|
GB202209588D0
(en)
|
2022-06-29 |
2022-08-10 |
Plant Bioscience Ltd |
Methods and compositions
|
WO2024069420A2
(en)
|
2022-09-29 |
2024-04-04 |
Pfizer Inc. |
Immunogenic compositions comprising an rsv f protein trimer
|
GB202215134D0
(en)
|
2022-10-13 |
2022-11-30 |
Prokarium Ltd |
Composition
|
GB202215576D0
(en)
|
2022-10-21 |
2022-12-07 |
Prokarium Ltd |
Circuit
|
WO2024153674A1
(en)
|
2023-01-18 |
2024-07-25 |
Novavax AB |
Methods of quantifying saponins present in particles comprising saponin and lipid
|